• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ethnicity and second-line antihypertensive medication response in the ASCOT Trial.

作者信息

Davis Jason T, Fung Maple M

机构信息

Department of Medicine, VA San Diego Healthcare System and University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0838, USA.

出版信息

Curr Hypertens Rep. 2011 Feb;13(1):8-10. doi: 10.1007/s11906-010-0169-4.

DOI:10.1007/s11906-010-0169-4
PMID:21080239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3016019/
Abstract
摘要

相似文献

1
Ethnicity and second-line antihypertensive medication response in the ASCOT Trial.ASCOT试验中的种族与二线抗高血压药物反应
Curr Hypertens Rep. 2011 Feb;13(1):8-10. doi: 10.1007/s11906-010-0169-4.
2
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.在 Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy 研究中，高血压患者接受降压和降脂治疗后的长期死亡率：一项随机化两因素试验的 16 年随访结果。
Lancet. 2018 Sep 29;392(10153):1127-1137. doi: 10.1016/S0140-6736(18)31776-8. Epub 2018 Aug 26.
3
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.ASCOT 试验中随机分组的患者中一线和二线降压治疗的血压反应的种族差异。
Am J Hypertens. 2010 Sep;23(9):1023-30. doi: 10.1038/ajh.2010.105. Epub 2010 Aug 19.
4
The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.
Am J Cardiovasc Drugs. 2006;6(5):327-34. doi: 10.2165/00129784-200606050-00005.
5
Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).血浆肾素活性是否可作为预测降压治疗的高血压患者肾脏和心血管结局的生物标志物？来自盎格鲁-斯堪的纳维亚心脏结局试验（ASCOT）的观察。
Eur Heart J. 2012 Dec;33(23):2970-9. doi: 10.1093/eurheartj/ehs241. Epub 2012 Aug 31.
6
Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).种族和族裔对美国女性抗高血压药物使用的影响：全国女性健康研究（SWAN）
J Am Heart Assoc. 2017 Feb 23;6(3):e004758. doi: 10.1161/JAHA.116.004758.
7
Do You Prefer Safety to Social Participation? Finnish Population-Based Preference Weights for the Adult Social Care Outcomes Toolkit (ASCOT) for Service Users.相较于社会参与，你更看重安全吗？芬兰基于人群的成年服务使用者社会护理结果工具包（ASCOT）偏好权重。
MDM Policy Pract. 2021 Jul 9;6(2):23814683211027902. doi: 10.1177/23814683211027902. eCollection 2021 Jul-Dec.
8
Quality of life in a broader perspective: Does ASCOT reflect the capability approach?更广阔视角下的生活质量：ASCOT 是否反映了能力方法？
Qual Life Res. 2018 May;27(5):1181-1189. doi: 10.1007/s11136-017-1756-5. Epub 2017 Dec 14.
9
Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?降脂治疗与多重危险因素患者：我们从盎格鲁-斯堪的纳维亚心脏结局试验（ASCOT）中学到了什么？
Am J Med. 2005 Dec;118 Suppl 12A:3-9. doi: 10.1016/j.amjmed.2005.09.002.
10
Evaluating trauma center quality: does the choice of the severity-adjustment model make a difference?
J Trauma. 2005 Jun;58(6):1265-71. doi: 10.1097/01.ta.0000169429.58786.c6.

本文引用的文献

1
Intensive blood-pressure control in hypertensive chronic kidney disease.高血压性慢性肾脏病的强化血压控制。
N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.
2
Renin-guided treatment of hypertension: time for action.肾素引导的高血压治疗：行动时刻已至。
Am J Hypertens. 2010 Sep;23(9):929-30. doi: 10.1038/ajh.2010.135.
3
Heterogeneity of blood pressure response to therapy.
Am J Hypertens. 2010 Sep;23(9):926-8. doi: 10.1038/ajh.2010.139.
4
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.贝那普利联合氨氯地平或氢氯噻嗪用于高危患者高血压的治疗
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
5
Genetic ancestry, population sub-structure, and cardiovascular disease-related traits among African-American participants in the CARDIA Study.冠心病风险发展研究中非洲裔美国参与者的遗传血统、人群亚结构及心血管疾病相关特征
Hum Genet. 2007 Jun;121(5):565-75. doi: 10.1007/s00439-007-0350-2. Epub 2007 Mar 14.
6
Pharmacogenomics of blood pressure response to antihypertensive treatment.血压对抗高血压治疗反应的药物基因组学
J Hypertens. 2005 Jul;23(7):1311-25. doi: 10.1097/01.hjh.0000173510.52987.68.
7
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告：JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.特定年龄的正常血压与血管性死亡率的相关性：对61项前瞻性研究中100万成年人个体数据的荟萃分析
Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.
9
Detection and control of high blood pressure in the community : Do we need a wake-up call?社区中高血压的检测与控制：我们是否需要警钟？
Hypertension. 1999 Sep;34(3):466-71. doi: 10.1161/01.hyp.34.3.466.
10
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.男性高血压的单药治疗。六种抗高血压药物与安慰剂的比较。退伍军人事务部抗高血压药物合作研究组。
N Engl J Med. 1993 Apr 1;328(13):914-21. doi: 10.1056/NEJM199304013281303.